Increased Sialylation of Anti-Thomsen-Friedenreich Antigen (CD176) Antibodies in Patients with Gastric Cancer: A Diagnostic and Prognostic Potential

Table 1

Characteristics of the subjects tested.

Group		Males	Females	M/F	Median age (range), yr
Donors	31	13	18	0.72	53.6 (31–70)
Benign diseases group^1	30	16	14	1.14	65.0 (44–76)
Noncancer^2	61	29	32	0.91	59.5 (31–76)
Cancer patients; Stages 1–4	142	82	60	1.36	69.2 (25–84)
Stage 1	39	19	20	0.95	66.0 (28–84)
Stage 2	32	18	14	1.28	66.5 (46–80)
Stage 3	51	30	21	1.42	67.0 (37–76)
Stage 4	20	15	5	3.0	65.0 (49–81)

A group of patients with chronic gastric diseases: peptic ulcer disease, ; chronic gastritis, ; and atrophic gastritis, . ²A combined group of donors and patients with nonmalignant stomach diseases. The number of subjects examined using a particular method is given in the corresponding section of the results.